Improved Parkinsons disease motor score in a single-arm open-label trial of febuxostat and inosine

BACKGROUND: Cellular energetics play an important role in Parkinsons disease etiology, but no treatments directly address this deficiency. Our past research showed that treatment with febuxostat and inosine increased blood hypoxanthine and ATP in healthy adults, and a preliminary trial in 3 Parkinso...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Hirohisa, Hattori, Tatsuya, Kume, Akito, Misu, Kenichiro, Ito, Takashi, Koike, Yu, Johnson, Todd A., Kamitsuji, Shigeo, Kamatani, Naoyuki, Sobue, Gen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
5300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458241/
https://www.ncbi.nlm.nih.gov/pubmed/32871874
http://dx.doi.org/10.1097/MD.0000000000021576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458241/
https://www.ncbi.nlm.nih.gov/pubmed/32871874
http://dx.doi.org/10.1097/MD.0000000000021576

Ejemplares similares